Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Eftychia StavrakakiDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Zineb BelcaidDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Rutger K BalversDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Lisette B VogelezangDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Wouter B L van den BosscheDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Demi AlderliestenDepartment of Pathology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.
Karishma LilaDepartment of Pathology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.
Thierry P P van den BoschDepartment of Pathology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.ORCID 0000-0002-7223-4565
Jacques J M van DongenCancer Research Center (IBMCC, Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, 37007 Salamanca, Spain.ORCID 0000-0002-3650-7087
Reno DebetsLaboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-3649-807X
Cristina TeodosioCancer Research Center (IBMCC, Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, 37007 Salamanca, Spain.ORCID 0000-0002-2097-7199
Clemens M F DirvenDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Martine L M LamfersDepartment of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-7745-9029
Funding
CT is the recipient of an USAL4EXCELLENCE fellowship, funded by the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie COFUND actions, cofunded by the Junta de Castilla y León, Spain. 101034371ErasmusMC Mrace program NASOAK Support Casper Foundation NA
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological Studies. · full record | OpenQuestion